{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:11:20Z","timestamp":1785409880860,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371159"],"award-info":[{"award-number":["32371159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070898"],"award-info":[{"award-number":["82070898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872793"],"award-info":[{"award-number":["31872793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.taap.2024.116876","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T11:11:49Z","timestamp":1709377909000},"page":"116876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mechanisms of adverse mammary effect induced by olanzapine and therapeutic interventions in rat model."],"prefix":"10.1016","volume":"485","author":[{"given":"Yingyue","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0253-7613.75681","article-title":"Breast enlargement associated with low dose olanzapine","volume":"43","author":"Aggarwal","year":"2011","journal-title":"Indian J Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.taap.2024.116876_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.comppsych.2016.08.009","article-title":"Hyperprolactinemia, prolactin-related side effects and quality of life in Chinese psychiatric patients","volume":"71","author":"An","year":"2016","journal-title":"Compr. Psychiatry"},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10549-011-1506-2","article-title":"The use of atypical antipsychotics and the risk of breast cancer","volume":"129","author":"Azoulay","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.taap.2024.116876_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-12114-7_1","article-title":"Prolactin (PRL) in adipose tissue: regulation and functions","volume":"846","author":"Ben-Jonathan","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.taap.2024.116876_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1592\/phco.29.1.64","article-title":"Antipsychotic-induced hyperprolactinemia","volume":"29","author":"Bostwick","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/dbio.1999.9271","article-title":"Prolactin controls mammary gland development via direct and indirect mechanisms","volume":"210","author":"Brisken","year":"1999","journal-title":"Dev. Biol."},{"issue":"6","key":"10.1016\/j.taap.2024.116876_bb0045","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/jcp.0b013e31815ac4e5","article-title":"Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives","volume":"27","author":"Byerly","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.taap.2024.116876_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.taap.2024.116876_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine - pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/030098589102800206","article-title":"Sexual dimorphism of the normal rat mammary gland","volume":"28","author":"Cardy","year":"1991","journal-title":"Vet. Pathol."},{"issue":"11","key":"10.1016\/j.taap.2024.116876_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2021.159024","article-title":"Mast cell and heparin promote adipogenesis in superficial fascia of rats","volume":"1866","author":"Chen","year":"2021","journal-title":"BBA-Mol. Cell Biol. Lipids"},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(97)00036-4","article-title":"The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations","volume":"26","author":"Crawford","year":"1997","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.taap.2024.116876_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0306-4530(01)00016-6","article-title":"Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients","volume":"26","author":"Esel","year":"2001","journal-title":"Psychoneuroendocrinology"},{"issue":"2 Suppl","key":"10.1016\/j.taap.2024.116876_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269216307087148","article-title":"Prolactin and dopamine: what is the connection? A review article","volume":"22","author":"Fitzgerald","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.taap.2024.116876_bb0090","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol. Rev."},{"issue":"3744","key":"10.1016\/j.taap.2024.116876_bb0095","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1126\/science.153.3744.1615","article-title":"Hypertrophy versus hyperplasia","volume":"153","author":"Goss","year":"1966","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.taap.2024.116876_bb0100","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00213-017-4730-6","article-title":"Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research","volume":"234","author":"Grigg","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.taap.2024.116876_bb0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1192\/apt.bp.115.014928","article-title":"Management of antipsychotic-induced hyperprolactinaemia","volume":"23","author":"Gupta","year":"2018","journal-title":"BJPsych Adv."},{"issue":"20","key":"10.1016\/j.taap.2024.116876_bb0110","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.taap.2024.116876_bb0115","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/00048674.2011.589044","article-title":"Antipsychotic-induced hyperprolactinaemia","volume":"45","author":"Inder","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.taap.2024.116876_bb0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.9758\/cpn.2022.20.4.675","article-title":"Risk of breast cancer in association with the use of second-generation antipsychotics","volume":"20","author":"Joo","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.taap.2024.116876_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semcdb.2020.10.005","article-title":"Prolactin: a hormone with diverse functions from mammary gland development to cancer metastasis","volume":"114","author":"Karayazi Atici","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.taap.2024.116876_bb0130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaac.2023.03.007","article-title":"Antipsychotic-related prolactin levels and sexual dysfunction in mentally ill youth: a 3-month cohort study","volume":"62","author":"Koch","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.taap.2024.116876_bb0135","article-title":"Olanzapine versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.taap.2024.116876_bb0140","article-title":"Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00213-002-1067-5","article-title":"Olanzapine-induced galactorrhea","volume":"162","author":"Licht","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.taap.2024.116876_bb0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1586\/14737175.6.6.811","article-title":"Olanzapine: a 5-year perspective","volume":"6","author":"Littrell","year":"2006","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.taap.2024.116876_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/a-1854-0185","article-title":"Pharmacological treatment of early-onset schizophrenia: a critical review, evidence-based clinical guidance and unmet needs","volume":"55","author":"Lopez-Morinigo","year":"2022","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.taap.2024.116876_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12888","article-title":"Metabolic functions of prolactin: physiological and pathological aspects","volume":"32","author":"Lopez-Vicchi","year":"2020","journal-title":"J. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/01926230601156260","article-title":"The rat mammary gland: morphologic changes as an indicator of systemic hormonal perturbations induced by xenobiotics","volume":"35","author":"Lucas","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2024.116876_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6475-8_1","article-title":"Overview of mammary gland development: a comparison of mouse and human","volume":"1501","author":"McNally","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.taap.2024.116876_bb0175","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/j.1440-1614.2005.01666_1.x","article-title":"Olanzapine-induced gynecomastia","volume":"39","author":"Mendhekar","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.taap.2024.116876_bb0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1614.2004.01346.x","article-title":"Olanzapine-induced galactorrhea in a woman with psychotic illness","volume":"38","author":"Mendhekar","year":"2004","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.taap.2024.116876_bb0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2016.07.018","article-title":"Safety and tolerability of long-acting injectable versus oral antipsychotics: a meta-analysis of randomized controlled studies comparing the same antipsychotics","volume":"176","author":"Misawa","year":"2016","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.taap.2024.116876_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1538\/expanim.17-0134","article-title":"Relationship between morphological development and sex hormone receptor expression of mammary glands with age in male rats","volume":"67","author":"Miyamoto","year":"2018","journal-title":"Exp. Anim."},{"issue":"4","key":"10.1016\/j.taap.2024.116876_bb0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.9758\/cpn.2018.16.4.361","article-title":"Comparative efficacy and safety of long-acting injectable and oral second-generation antipsychotics for the treatment of schizophrenia: a systematic review and meta-analysis","volume":"16","author":"Park","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"5","key":"10.1016\/j.taap.2024.116876_bb0200","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.taap.2024.116876_bb0205","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/bcp.13661","article-title":"Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study","volume":"84","author":"Pottegard","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human","volume":"75","author":"Pouzet","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s42000-022-00373-y","article-title":"Prolactin and its significance in the placenta","volume":"21","author":"Rana","year":"2022","journal-title":"Hormones (Athens)"},{"issue":"3","key":"10.1016\/j.taap.2024.116876_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2024.116876_bb0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2021.08.022","article-title":"Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medications","volume":"143","author":"Redman","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00213-005-0230-1","article-title":"Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data","volume":"184","author":"Rourke","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/0253-7176.203118","article-title":"Asymmetric, tender gynecomastia induced by olanzapine in a young male","volume":"39","author":"Shahi","year":"2017","journal-title":"Indian J. Psychol. Med."},{"issue":"17\u201318","key":"10.1016\/j.taap.2024.116876_bb0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.lfs.2011.02.014","article-title":"Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats","volume":"88","author":"Shobo","year":"2011","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.taap.2024.116876_bb0245","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/stem.2338","article-title":"Fascia origin of adipose cells","volume":"34","author":"Su","year":"2016","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.taap.2024.116876_bb0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/cap.2009.0098","article-title":"No unexpected adverse events and biochemical side effects of olanzapine as adjunct treatment in adolescent girls with eating disorders","volume":"21","author":"Swenne","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.taap.2024.116876_bb0255","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.pnpbp.2010.06.002","article-title":"Induction of subcutaneous adipose proliferation by olanzapine in rodents","volume":"34","author":"Tan","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.taap.2024.116876_bb0260","doi-asserted-by":"crossref","first-page":"O461","DOI":"10.1107\/S0108270111043952","article-title":"Polymorphic form IV of olanzapine","volume":"67","author":"Thakuria","year":"2011","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.taap.2024.116876_bb0265","first-page":"100148","article-title":"Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia","volume":"6","author":"Vadiei","year":"2022","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"issue":"1","key":"10.1016\/j.taap.2024.116876_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/toxsci\/kfj120","article-title":"Altered mammary gland development in male rats exposed to genistein and methoxychlor","volume":"91","author":"Wang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2024.116876_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2046-4053-1-33","article-title":"Treatment of hyperprolactinemia: a systematic review and meta-analysis","volume":"1","author":"Wang","year":"2012","journal-title":"Syst. Rev."},{"key":"10.1016\/j.taap.2024.116876_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/bjp.182.3.199","article-title":"Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review","volume":"182","author":"Wieck","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.taap.2024.116876_bb0285","doi-asserted-by":"crossref","first-page":"718800","DOI":"10.3389\/fphar.2021.718800","article-title":"The relationships between hyperprolactinemia, metabolic disturbance, and sexual dysfunction in patients with schizophrenia under olanzapine treatment","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0290","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/excr.1998.4373","article-title":"Adipocyte-epithelial interactions regulate the in vitro development of normal mammary epithelial cells","volume":"247","author":"Zangani","year":"1999","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2019.158585","article-title":"Cytological and functional characteristics of fascia adipocytes in rats: a unique population of adipocytes","volume":"1865","author":"Zhang","year":"2020","journal-title":"BBA-Mol. Cell Biol. Lipids"},{"issue":"6","key":"10.1016\/j.taap.2024.116876_bb0300","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/JCP.0000000000000579","article-title":"Efficacy and safety of adjunctive aripiprazole in schizophrenia: meta-analysis of randomized controlled trials","volume":"36","author":"Zheng","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.116876_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jc.2002-021255","article-title":"Prolactin expression and secretion by human breast glandular and adipose tissue explants","volume":"88","author":"Zinger","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:04:02Z","timestamp":1758575042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":61,"alternative-id":["S0041008X24000747"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116876","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of adverse mammary effect induced by olanzapine and therapeutic interventions in rat model.","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116876"}}